Back
Axsome Therapeutics Stock Price Chart
FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report here
Sell
38
AXSM
Axsome Therapeutics
Last Price:
$103.78
Seasonality Move:
5.58%
7 Day Trial
ALL ACCESS PASS
$
7
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AXSM is experiencing selling pressure, which indicates risk of future bearish movement.
Axsome Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 109.45 | Sell |
| 20-day SMA: | 108.06 | Sell |
| 50-day SMA: | 112.46 | Sell |
| 200-day SMA: | 99.63 | Buy |
| 8-day EMA: | 107.87 | Sell |
| 20-day EMA: | 108.53 | Sell |
| 50-day EMA: | 109.91 | Sell |
| 200-day EMA: | 101.05 | Buy |
Axsome Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.66 | Sell |
| Relative Strength Index (14 RSI): | 40.64 | Sell |
| Chaikin Money Flow: | -577051 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (101.85 - 111.27) | Sell |
| Bollinger Bands (100): | (93.8 - 123.14) | Sell |
Axsome Therapeutics Technical Analysis
| May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Axsome Therapeutics Stock
Is Axsome Therapeutics Stock a Buy?
-
Axsome Therapeutics share price is 103.67 while AXSM 8-day simple moving average is 109.45, which is a Sell signal.
-
The stock price of AXSM is 103.67 while Axsome Therapeutics 20-day SMA is 108.06, which makes it a Sell.
-
Axsome Therapeutics 50-day simple moving average is 112.46 while AXSM share price is 103.67, making it a Sell technically.
-
AXSM stock price is 103.67 and Axsome Therapeutics 200-day simple moving average is 99.63, creating a Buy signal.
AXSM Technical Analysis vs Fundamental Analysis
Sell
38
Axsome Therapeutics (AXSM)
is a Sell
Is Axsome Therapeutics a Buy or a Sell?
-
Axsome Therapeutics stock is rated a SellThe current Axsome Therapeutics [AXSM] share price is $103.67. The Score for AXSM is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
Axsome Therapeutics Stock Info
Market Cap:
5.1B
Price in USD:
103.67
Share Volume:
874.1K
Axsome Therapeutics 52-Week Range
52-Week High:
139.13
52-Week Low:
64.11
Sell
38
Axsome Therapeutics (AXSM)
is a Sell
Axsome Therapeutics Share Price Forecast
-
What is the Axsome Therapeutics stock price today?The Axsome Therapeutics stock price is 103.67 USD today.
-
Will AXSM stock go up or go down?Axsome Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Axsome Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Axsome Therapeutics is overvalued.
Is Axsome Therapeutics Stock a Buy?
-
Axsome Therapeutics share price is 103.67 while AXSM 8-day exponential moving average is 107.87, which is a Sell signal.
-
The stock price of AXSM is 103.67 while Axsome Therapeutics 20-day EMA is 108.53, which makes it a Sell.
-
Axsome Therapeutics 50-day exponential moving average is 109.91 while AXSM share price is 103.67, making it a Sell technically.
-
AXSM stock price is 103.67 and Axsome Therapeutics 200-day simple moving average is 101.05, creating a Buy signal.
Fundamental Analysis of Axsome Therapeutics
Is Axsome Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.47 per share, an increase next quarter of $0.91 per share, an increase this year of $1.40 per share, and an increase next year of $5.11 per share.
Technical Analysis of Axsome Therapeutics
Should I short Axsome Therapeutics stock?
-
AXSM Moving Average Covergence Divergence (MACD) indicator is -0.66, suggesting Axsome Therapeutics is a Sell
-
Axsome Therapeutics Relative Strength Index (RSI) is 40.64, which suggest Axsome Therapeutics is oversold
-
The Bollinger Bands (25) for Axsome Therapeutics is (101.85 - 111.27), which suggest Axsome Therapeutics is a Sell
-
The Bollinger Bands (100) for Axsome Therapeutics is (93.8 - 123.14), which suggest Axsome Therapeutics is a Sell
* Axsome Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.